# Architecture Delta Report — BATCH2-CONTEXT-COMPLETION-1

## 1. Architectural debt removed

- Runtime evaluator gap: `disclosed` requirement mode and snapshot disclosure keys now implemented.
- Package metadata misclassification debt for hormone therapy, AAS exposure, steroid use, long-term medications, and illness/recovery status remediated on 6 packages.
- Clearance register `blocked_pending_context_semantics` count reduced from 9 to 0.

## 2. New architectural debt created

- FT3 low still lacks `thyroid_medication_disclosed` in package metadata despite clearance register listing it as required disclosed context.
- Orchestrator still evaluates signals before full governed context assembly (`ARCH-ORCH-RESTRUCTURE-1`).
- Activation remains blocked pending clinical sign-off for all androgen packages.

## 3. Movement toward target architecture

**Closer.** The target chain (governed semantics → deterministic runtime → thin loaders → DTOs) is strengthened: disclosure is now distinguishable from positive presence at runtime without LLM inference or clinical heuristics. No frontend or SSOT drift introduced.

## 4. Carry-forward impact

| Item | Impact |
|------|--------|
| CF-CONTEXT-SEMANTICS-1 | Remains Resolved; note updated to include runtime implementation |
| CF-BATCH2-010 | Remains Open |
| CF-CONTEXT-MOD-3 | Remains Resolved |
| ARCH-ORCH-RESTRUCTURE-1 | Remains Open |

No new carry-forwards created.

## 5. Day-One Architecture maturity assessment

Context-dependent evaluation maturity increased from taxonomy-only to runtime-enforced disclosed semantics. Activation maturity unchanged — 0 packages activated. Overall Day-One readiness improved incrementally on Intelligence Core determinism; launch activation posture unchanged.

## Overall verdict

Successful implementation sprint with zero activation. Architectural integrity preserved. Merge route: Claude audit → GPT architectural review → human approval.
